Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424. https://doi.org/10.3322/caac.21492
Van der Jeught K, Xu HC, Li YJ, Lu XB, Ji G (2018) Drug resistance and new therapies in colorectal cancer. World J Gastroenterol 24:3834–3848. https://doi.org/10.3748/wjg.v24.i34.3834
Article CAS PubMed PubMed Central Google Scholar
Falzone L, Scola L, Zanghì A, Biondi A, Di Cataldo A, Libra M, Candido S (2018) Integrated analysis of colorectal cancer microRNA datasets: identification of microRNAs associated with tumor development. Aging 10:1000–1014. https://doi.org/10.18632/aging.101444
Article PubMed PubMed Central Google Scholar
Brenner H, Kloor M, Pox CP (2014) Colorectal cancer. Lancet 383:1490–1502. https://doi.org/10.1016/S0140-6736(13)61649-9
Strul H, Arber N (2007) Screening techniques for prevention and early detection of colorectal cancer in the average-risk population. Gastrointest Cancer Res 1:98–106
PubMed PubMed Central Google Scholar
Schetter AJ, Okayama H, Harris CC (2012) The role of microRNAs in colorectal cancer. Cancer J 18(3):244–252
Article CAS PubMed PubMed Central Google Scholar
Fadhil W, Ibrahem S, Seth R, AbuAli G, Ragunath K, Kaye P et al (2012) The utility of diagnostic biopsy specimens for predictive molecular testing in colorectal cancer. Histopathology 61(6):1117–1124
Hood L, Galas D (2003) The digital code of DNA. Nature 421(6921):444–448
Amani D, Khalilnezhad A, Ghaderi A, Niikawa N, Yoshiura K (2014) Transforming growth factor beta1 (TGFbeta1) polymorphisms and breast cancer risk. Tumour Biol 35(5):4757–4764
Article CAS PubMed Google Scholar
Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281–297
Article CAS PubMed Google Scholar
Garo LP, Murugaiyan G (2016) Contribution of MicroRNAs to autoimmune diseases. Cell Mol Life Sci 73:2041–2051
Article CAS PubMed Google Scholar
Li X, Nie J, Mei Q, Han WD (2016) MicroRNAs: novel immunotherapeutic targets in colorectal carcinoma. World J Gastroenterol 22:5317–5331
Article CAS PubMed PubMed Central Google Scholar
Chae YS et al (2013) A miR-146a polymorphism (rs2910164) predicts risk of and survival from colorectal cancer. Anticancer Res 33:3233–3239
Nakajima G, Hayashi K, Xi Y, Kudo K, Uchida K, Takasaki K, Yamamoto M, Ju J (2006) Non-coding MicroRNAs hsa-let-7g and hsa-miR-181b are associated with chemoresponse to S-1 in Colon Cancer. Cancer Genom Proteom 3:317–324
Schetter AJ, Leung SY, Sohn JJ, Zanetti KA, Bowman ED, Yanaihara N, Yuen ST, Chan TL, Kwong DL, Au GK, Liu CG, Calin GA, Croce CM, Harris CC (2008) MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 299:425–436
Article CAS PubMed PubMed Central Google Scholar
Slaby O, Svoboda M, Fabian P, Smerdova T, Knoflickova D, Bednarikova M, Nenutil R, Vyzula R (2007) Altered expression of miR- 21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer. Oncology 72:397–402
Article CAS PubMed Google Scholar
Slaby O, Bienertova-Vasku J, Svoboda M, Vyzula R (2012) Genetic polymorphisms and microRNAs: new direction in molecular epidemiology of solid cancer. J Cell Mol Med 16:8–21
Article CAS PubMed Google Scholar
Hu Z, Liang J, Wang Z, Tian T, Zhou X, Chen J, Miao R, Wang Y, Wang X, Shen H (2009) Common geneticvariants in pre-microRNAs were associated with increased risk of breast cancer in Chinese women. Hum Mutat 30:79–84
Article CAS PubMed Google Scholar
Chen H, Sun LY, Chen LL, Zheng HQ, Zhang QF (2011) A variant in microRNA-196a2 is not associatedwith susceptibility to and progression of colorectal cancer in Chinese. Intern Med J. https://doi.org/10.1111/j.1445-5994.2011.02434.x
Omrane I, Kourda N, Stambouli N, Privat M, Medimegh I, Arfaoui A et al (2014) MicroRNAs 146a and 147b biomarkers for colorectal tumor’s localization. Biomed Res Int 2014:584852
Article PubMed PubMed Central Google Scholar
Hezova R, Kovarikova A, Bienertova-Vasku J, Sachlova M, Redova M, Vasku A et al (2012) Evaluation of SNPs in miR-196-a2, miR-27a and miR-146a as risk factors of colorectal cancer. World J Gastroenterol 18(22):2827–2831
Article CAS PubMed PubMed Central Google Scholar
Smith RA, Jedlinski DJ, Gabrovska PN, Weinstein SR, Haupt L, Griffiths LR (2012) A genetic variant located in miR-423 is associated with reduced breast cancer risk. Cancer Genom Proteom 9(3):115–118
Ma Y, Wang R, Zhang J, Li W, Gao C, Liu J et al (2014) Identification of miR-423 and miR-499 polymorphisms on affecting the risk of hepatocellular carcinoma in a large-scale population. Genet Test Mol Biomark 18(7):516–524
Chen C, Zhang Y, Zhang L, Weakley SM, Yao Q (2011) MicroRNA-196: critical roles and clinical applications in development and cancer. J Cell Mol Med 15(1):14–23
Article CAS PubMed PubMed Central Google Scholar
Yungang W, Xiaoyu L, Pang T, Wenming L, Pan X (2014) miR-370 targeted FoxM1 functions as a tumor suppressor in laryngeal squamous cell carcinoma (LSCC). Biomed Pharmacother 68:149–154
Article CAS PubMed Google Scholar
Chen XP, Chen YG, Lan JY, Shen ZJ (2014) MicroRNA-370 suppresses proliferation and promotes endometrioid ovarian cancer chemosensitivity to cDDP by negatively regulating ENG. Cancer Lett 353:201–210
Article CAS PubMed Google Scholar
Wu Z, Sun H, Zeng W, He J, Mao X (2012) Upregulation of MircoRNA-370 induces proliferation in human prostate cancer cells by downregulating the transcription factor FOXO1. PLoS ONE 7:e45825
Article CAS PubMed PubMed Central Google Scholar
Luo P, He T, Jiang R, Li G (2015) MicroRNA-423-5p targets O-GlcNAc transferase to induce apoptosis in cardiomyocytes. Mol Med Rep 12:1163–1168
Article CAS PubMed Google Scholar
Li FX, Yang XX, Hu NY, Du HY, Ma Q, Li M (2012) Single-nucleotide polymorphism associations for colorectal cancer in southern chinese population. Chin J Cancer Res 24(1):29–35
Article PubMed PubMed Central Google Scholar
Qi JH, Wang J, Chen J, Shen F, Huang JT, Sen S et al (2014) High-resolution melting analysis reveals genetic polymorphisms in MicroRNAs confer hepatocellular carcinoma risk in Chinese patients. BMC Cancer 14:643
Article PubMed PubMed Central Google Scholar
Abdul-Hadi Chabuk H, Jameel ZI (2021) Relationship between the monoamine oxidase gene overactivity and the otherpathophysiological and behavioral parameters implicated in memory deficiency in albino Winstar rats as Alzheimer’s diseasemodel. J Appl Nat Sci 13(4):1274–1282. https://doi.org/10.31018/jans.v13i4.3024
Jameel ZI, Lawi ZK, Al-Dujaili NH (2019) Investigation of micro RNA gene polymorphism (Rs11614913) inpatients with type 2 diabetes in Najaf City. Biochem Cell Arch 19(1):2027–2030
Byun SO, Fang Q, Zhou H, Hickford JGH (2009) An effectivemethod for silver-staining DNA in large numbers of poly-acrylamide gels. Anal Biochem 385(1):174–175
Article CAS PubMed Google Scholar
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424
Global Burden of Disease Cancer Collaboration, Fitzmaurice C, Abate D, Abbasi N, Abbastabar H, Abd-Allah F (2019) Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the global burden of disease study. JAMA Oncol 5(12):1749–1768
Article PubMed Central Google Scholar
Moridikia A, Mirzaei H, Sahebkar A, Salimian J (2018) MicroRNAs: potential candidates for diagnosis and treatment of colorectal cancer. J Cell Physiol 233(2):901–913
Article CAS PubMed Google Scholar
Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F (2017) Global patterns and trends in colorectal cancer incidence and mortality. Gut 66(4):683–6891
留言 (0)